European Advisory Group on the Expanded Programme on Immunization : report on the 12th meeting, Copenhagen, Denmark, 21 November 1996
РезюмеAt its twelfth meeting, the European Advisory Group (EAG) confirmed that the first priority for measles control was the achievement of high coverage with a single dose of vaccine, though this would not serve to eliminate the disease. The interruption of transmission needed to be maintained, and this could be achieved with supplementary vaccination, either through repeated campaigns or by the administration of second doses. Whichever approach was used, it was essential that the reaccumulation of susceptibles was prevented. The EAG endorsed the importance of achieving very high coverage of primary immunization with DTP vaccine. This should be completed before six months of age. The first booster could be given at 16-36 months of age, with another (DT) before school entry and a third (Td) on leaving school. This recommendation applied to all European countries. In a number of countries, especially those presently experiencing or having recently experienced epidemic diphtheria, a further booster should be given during the school years. Where the risk of diphtheria was considered high, periodic booster doses for adults would be necessary to prevent resurgence of the disease as immunity waned. On poliomyelitis, the EAG noted the significant impact of Operation MECACAR and the increasing awareness that remaining outbreaks of poliomyelitis in the Region had often followed importation of the disease. The EAG endorsed the plan of action for 1997 proposed by the Regional Office. In countries where poliomyelitis was still endemic or had become nonendemic within the past three years, the surveillance of acute flaccid paralysis (AFP) remained the recommended form of surveillance, especially for certification purposes. However, in countries where polioviruses had not been detected for many years, and AFP surveillance was not appropriate, other means of surveillance would need to be used. The EAG recommended that the Regional Office commission a position paper to review the options for laboratory-based or other surveillance techniques, so that appropriate guidelines could be issued
European Advisory Group on the Expanded Programme on Immunization. Meeting (12th: 1996: Copenhagen, Denmark) & World Health Organization. Regional Office for Europe. (1997). European Advisory Group on the Expanded Programme on Immunization : report on the 12th meeting, Copenhagen, Denmark, 21 November 1996. Copenhagen : WHO Regional Office for Europe. http://www.who.int/iris/handle/10665/107806
ОписаниеEUR/ICP/CMDS 01 01 11(A)
Gov't Doc #EUR/ICP/CMDS 01 01 11(A)
МетаданныеПоказать полную информацию
Публикации того же автора или по той же теме
Intercountry meeting on vaccine procurement for self-procuring countries (central and eastern Europe, Turkey and NIS) : report on a WHO meeting, Copenhagen, Denmark 3-4 September 2002 World Health Organization. Regional Office for Europe (EUR/03/5043768, 2003)During the past decade major progress in vaccine procurement has taken place in the countries of central and eastern Europe (CCEE), Turkey and the newly independent states (NIS) using bidding mechanisms opened up in the global market. However, because of changes in the market, the process has become more complex and countries need to adapt. It is in this context that the Intercountry Meeting on Vaccine Procurement for self-procuring countries was held. The main objective of the meeting was to provide participants with detailed information on ...
Extraordinary meeting of the European Technical Advisory Group of Experts on Immunization (ETAGE). 30 January 2015 Copenhagen, Denmark Неизвестный автор (2015)The European Technical Advisory Group of Experts on Immunization (ETAGE) met on 30 January 2015 to review and discuss measles and rubella elimination in the WHO European Region and to be briefed and provide input on the advocacy plan for the European Vaccine Action Plan (EVAP). Representatives of the European Regional Verification Commission (RVC) participated at the meeting, to report on their November 2014 review of regional measles and rubella elimination progress as reported by Member States for 2013.